Skip to main content

Advertisement

SpringerLink
Log in

Glucose Transporter 1, Distribution in the Brain and in Neural Disorders: Its Relationship With Transport of Neuroactive Drugs Through the Blood-Brain Barrier

  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

Facilitative glucose transport is mediated by one or more of the members of the closely related glucose transporter (GLUT) family. Thirteen members of the GLUT family have been described thus far. GLUT1 is a widely expressed isoform that provides many cells with their basic glucose requirement. It is also the primary transporter across the blood-brain barrier. This review describes the distribution and expression of GLUT1 in brain in different pathophysiological conditions including Alzheimer’s disease, epilepsy, ischemia, or traumatic brain injury. Recent investigations show that GLUT1 mediates the transport of some neuroactive drugs, such as glycosylated neuropeptides, low molecular weight heparin, and d-glucose derivatives, across the blood-brain barrier as a delivery system. By utilizing such highly specific transport mechanisms, it should be possible to establish strategies to regulate the entry of candidate drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Au, K. K., Liong, E., Li, J. Y., Li, P. S., Liew, C. C., Kwok, T. T., Choy, Y. M., Lee, C. Y., and Fung, K. P. (1997). Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development. J. Cell Biochem. 67:131–135.

    PubMed  CAS  Google Scholar 

  • Bergsneider, M., Hovda, D. A., Shalmon, E., Kelly, D. F., Vespa, P. M., Martin, N. A., Phelps, M. E., McArthur, D. L., Caron, M. J., Kraus, J. F., and Becker, D. P. (1997). Cerebral hyperglycolysis following severe traumatic brain injury in humans: A positron emission tomography study. J. Neurosurg. 86:241–251.

    Article  PubMed  CAS  Google Scholar 

  • Bilsky, E. J., Egleton, R. D., Mitchell, S. A., Palian, M. M., Davis, P., huber, J. D., Jones, H., Yamamura, H. I., Janders, J., Davis, T. P., Porreca, F., Hruby, V. J., and Polt, R. (2000). Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability. J. Med. Chem. 43:2586– 2590.

    PubMed  CAS  Google Scholar 

  • Boado, R. J. (1998a). Molecular regulation of the blood-brain barrier GLUT 1 glucose transporter by brain-derived factors. J. Neural. Transm. Suppl. 53:323–331.

    CAS  Google Scholar 

  • Boado, R. J. (1998b). Brain-derived peptides increase blood-brain barrier GLUT1 glucose transporter gene expression via mRNA stabilization. Neurosci. Lett. 255:147–150.

    CAS  Google Scholar 

  • Bolz, S., Farrell, C. L., Dietz, K., and Wolburg, H. (1996). Subcellular distribution of glucose transporter (GLUT-1) during development of the blood-brain barrier in rats. Cell Tissue Res. 284:355-365.

    PubMed  CAS  Google Scholar 

  • Bourasset, F., Cisternino, S., Temsamani, J., and Scherrmann, J. M. (2003). Evidence for an active transport of morphine-6-β-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. J. Neurochem. 86:1564–1567.

    PubMed  CAS  Google Scholar 

  • Chavez, J. C., and LaManna, J. C. (2002). Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: Potential role of insulin-like growth factor-1. J. Neurosci. 22:8922–8931.

    PubMed  CAS  Google Scholar 

  • Cheng, C. M., Cohen, M., Wang, J., and Bondy, C. A. (2001). Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J. 15:907–915.

    PubMed  CAS  Google Scholar 

  • Cornford, E. M., Gee, M. N., Swartz, B. E., Mandelkern, M. A., Blahd, W. H., Landaw, E. M., and Delgado-Escueta, A. V. (1998a). Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: Reduced capillary influx. Ann. Neurol. 43:801-808.

    CAS  Google Scholar 

  • Cornford, E. M., Hyman, S., Black, K. L., Cornford, M. E., Vinters, H. V., and Pardridge, W. M. (1995). High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium. J. Neuropathol. Exp. Neurol. 54:842–851.

    PubMed  CAS  Google Scholar 

  • Cornford, E. M., Hyman, S., Cornford, M. E., and Caron, M. J. (1996). Glut1 glucose transporter activity in human brain injury. J. Neurotrauma 13:523–536.

    Article  PubMed  CAS  Google Scholar 

  • Cornford, E. M., Hyman, S., Cornford, M. E., Landaw, E. M., and Delgado-Escueta, A. V. (1998b). Interictal seizure resections show two configurations of endothelial GLUT1 glucose transporter in the human blood-brain barrier. J. Cereb. Blood Flow Metab. 18:26–42.

    CAS  Google Scholar 

  • Cornford, E. M., Hyman, S., and Pardridge, W. M. (1993). An electron microscopic immunogold analysis of developmental up-regulation of the blood-brain barrier GLUT1 glucose transporter. J. Cereb. Blood Flow Metab. 13:841–854.

    PubMed  CAS  Google Scholar 

  • Doege, H., Bocianski, A., Scheepers, A., Axer, H., Eckel, J., Joost, H. G., and Schürmann, A. (2001). Characterization of glucose transporter 10 (GLUT10), a novel heart and skeletal muscle-specific sugar transport facilitator. Diabetes 50(Suppl 2):A277–A278.

    Google Scholar 

  • Doege, H., Schürmann, A., Bahrenberg, G., Brauers, A., and Joost, H. G. (2000). GLUT8, a novel member of the sugar transport facilitator family with glucose transport activity. J. Biol. Chem. 275:16275–16280.

    PubMed  CAS  Google Scholar 

  • Egleton, R. D., and Davis, T. P. (1997). Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 18:1431–1439.

    PubMed  CAS  Google Scholar 

  • Egleton, R. D., Mitchell, S. A., Huber, J. D., Janders, J., Stropova, D., Polt, R., Yamamura, H. I., Hruby, V. J., and Davis, T. P. (2000). Improved bioavailability to the brain of glycosylated met-enkephalin analogs. Brain Res. 881:37–46.

    PubMed  CAS  Google Scholar 

  • Farrell, C. L., and Pardridge, W. M. (1991). Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: An electron microscopic immunogold study. Proc. Natl. Acad. Sci. U.S.A. 88:5779–5783.

    PubMed  CAS  Google Scholar 

  • Filira, F., Biondi, L., Cavaggion, F., Scolaro, B., and Rocchi, R. (1990). Synthesis of O-glycosylated tuftsins by utilizing threonine derivatives containing an unprotected monosaccharide moiety. Int. J. Pept. Protein Res. 36:86–96.

    Article  PubMed  CAS  Google Scholar 

  • Halmos, T., Santarromana, M., Antonakis, K., and Scherman, D. (1997). Synthesis of O-methylsulfonyl derivatives of D-glucose as potential alkylating agents for targeted drug delivery to the brain: Evaluation of their interaction with the human erythrocyte Glut1 hexose transporter. Carbohyd. Res. 299:15–21.

    CAS  Google Scholar 

  • Hamlin, G. P., Cernak, I., Wixey, J. A., and Vink, R. (2001). Increased expression of neuronal glucose transporter 3 but not glial glucose transporter 1 following severe diffuse traumatic brain injury in rats. J. Neurotrauma 18:1011–1018.

    PubMed  CAS  Google Scholar 

  • Harr, S. D., Simonian, N. A., and Hyman, B. T. (1995). Functional alterations in Alzheimer’s disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J. Neuropathol. Exp. Neurol. 54:38–41.

    PubMed  CAS  Google Scholar 

  • Horvat, S., Horvat, J., Varga-Defterdarovic, L., Pavelic, K., Chung, N. N., and Schiller, P. W. (1993). Methionine-enkephalin related glycoconjugates: Synthesis and biological activity. Int. J. Pept. Protein Res. 41:399–404.

    Article  PubMed  CAS  Google Scholar 

  • Janigro, D. (1999). Blood-brain barrier, ion homeostasis, and epilepsy: Possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Res. 37:223–232.

    PubMed  CAS  Google Scholar 

  • Joost, H. G., Doege, H., Bocianski, A., and Schürmann, A. (2001). Erratum: Nomenclature of the GLUT family of sugar transport facilitators, GLUT6, GLUT9, GLUT10, and Glut11. Biochem. J. 358:791–792.

    CAS  Google Scholar 

  • Joost, H. G., and Thorens, B. (2001). The extended GLUT family of sugar/polyol transport facilitators: Nomenclature, sequence characteristics, and potential function of its novel members. Mol. Membr. Bio. 18:247–256.

    CAS  Google Scholar 

  • Kayano, T., Burant, C. F., Fukumoto, H., Gould, G. M., Fan, Y.-S., Eddy, R. L., Byers, M. G., Shows, T. B., Seino, S., and Bell, G. I. (1990). Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6). J. Biol. Chem. 265:13276–13282.

    PubMed  CAS  Google Scholar 

  • Klepper, J., Diefenbach, S., Kohlschutter, A., and Voit, T. (2004). Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. Prostaglandins Leukot. Essent. Fatty Acids 70:321–327.

    PubMed  CAS  Google Scholar 

  • Kondo, F., Asanuma, M., Miyazaki, I., Kondo, Y., Tanaka, K., Makino, H., and Ogawa, N. (2001). Progressive cortical atrophy after forebrain ischemia in diabetic rats. Neurosci. Res. 39:339–346.

    PubMed  CAS  Google Scholar 

  • Kriss, C. T., Lou, B.-S., Szabo, L. Z., Mitchell, S. A., Hruby, V. J., and Polt, R. (2000). Enkephalin-based drug design: Conformational analysis of O-linked glycopeptides by NMR and molecular modeling. Tetrahedron-Asymmetr. 11:9–25.

    CAS  Google Scholar 

  • Leino, R. L., Gerhart, D. Z., Duelli, R., Enerson, B. E., and Drewes, L. R. (2001). Diet-induced ketosis increases monocarboxylate transporter (MCTl) levels in rat brain. Neurochem. Int. 38:519–527.

    PubMed  CAS  Google Scholar 

  • Leveugle, B., Ding, W., Laurence, F., Dehouck, M. P., Scanameo, A., Cecchelli, R., and Fillit, H. (1998). Heparin oligosaccharides that pass the blood-brain barrier inhibit beta-amyloid precursor protein secretion and heparin binding to beta-amyloid peptide. J. Neurochem. 70:736-744.

    Article  PubMed  CAS  Google Scholar 

  • Ma, Q., Dudas, B., Hejna, M., Cornelli, U., Lee, J. M., Lorens, S., Mervis, R., Hanin, I., and Fareed, J. (2002). The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3. Thromb. Res. 105:447–53.

    PubMed  CAS  Google Scholar 

  • Maher, F. (1995). Immunolocalization of GLUT1 and GLUT3 glucose transporters in primary cultured neurons and glia. J. Neurosci. Res. 42:459–469.

    PubMed  CAS  Google Scholar 

  • Maher, F., Davies-Hill, T. M., Lysko, P. G., Henneberry, R. C., and Simpson, I. A. (1991). Expression of two glucose transporters, GLUT1 and GLUT3. Mol. Cell Neurosci. 2:351–360.

    CAS  PubMed  Google Scholar 

  • Maher, F., Vannucci, S. J., and Simpson, I. A. (1994). Glucose transporter proteins in brain. FASEB J. 8:1003–1011.

    PubMed  CAS  Google Scholar 

  • McVie-Wylie, A. J., Lamson, D. R., and Chen, Y. T. (2001). Molecular cloning of a novel member of the GLUT family of transporters SLC2a10 (GLUT10), localized on chromosome 20q13.1: A candidate gene for NIDDM susceptibility. Genomics 72:113–117.

    PubMed  CAS  Google Scholar 

  • Mitchell, S. A., Pratt, M. R., Hruby, V. J., and Polt, R. (2001). Solid-phase synthesis of O-linked glycopeptide analogues of enkephalin. J. Org. Chem. 66:2327–2342.

    PubMed  CAS  Google Scholar 

  • Mooradian, A. D., Chung, H. C., and Shah, G. N. (1997). GLUT-l expression in the cerebra of patients with Alzheimer’s disease. Neurobiol. Aging 18:469–474.

    PubMed  CAS  Google Scholar 

  • Mueckler, M. (1994). Facilitative glucose transporters. Eur. J. Biochem. 219:713–725.

    PubMed  CAS  Google Scholar 

  • Nicchia, G. P., Frigeri, A., Liuzzi, G. M., and Svelto, M. (2003). Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes. FASEB J. 17:1508–1510.

    PubMed  CAS  Google Scholar 

  • Olson, A. L., and Pessin, J. E. (1996). Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu. Rev. Nutr. 16:235–256.

    PubMed  CAS  Google Scholar 

  • Pardridge, W. M., and Boado, R. J. (2000). Molecular cloning and gene expression of the blood-brain barrier glucose transporter. In Pardridge, W. M. (ed.), The Blood-Brain Barrier, Raven, New York, pp. 395–440.

    Google Scholar 

  • Phay, J. E., Hussain, H. B., and Moley, J. F. (2000). Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics 66:217–220.

    PubMed  CAS  Google Scholar 

  • Polt, R., Porreca, F., Szabo, L. Z., Bilsky, E. J., Davis, P., Abbruscato, T. J., Davis, T. P., Harvath, R., Yamamura, H. I., and Hruby, V. J. (1994). Glycopeptide enkephalin analogues produce analgesia in mice: Evidence for penetration of the blood-brain barrier. Proc. Natl. Acad. Sci. 91:7114–7118.

    PubMed  CAS  Google Scholar 

  • Richard, D. E., and Thomas, P. D. (1997). Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 18:1431–1439.

    Google Scholar 

  • Rodriguez, R. E., Rodriguez, F. D., Sacristan, M. P., Torres, J. L., Valencia, G., and Garcia Anton, J. M. (1989). New glycosylpeptide with high antinoceptive activity. Neurosci. Lett. 101:89– 94.

    PubMed  CAS  Google Scholar 

  • Rogers, S., Macheda, M. L., Docherty, S. E., Carty, M. D., Henderson, M. A., Soeller, W. C., Gibbs, E. M., James, D. E., and Best, J. D. (2002). Identification of a novel glucose transporter-like protein, GLUT-12. Am. J. Physiol. Endocrinol. Metab. 282:E733–E738.

    PubMed  CAS  Google Scholar 

  • Sasaki, T., Minoshima, S., Shiohama, A., Shinitani, A., Shimizu, A., Asakawa, S., Kawasaki, K., and Shimizu, N. (2001). Molecular cloning of a member of the facilitative glucose transporter gene family GLUT11(SLC2A11) and identification of transcription variants. Biochem. Biophys. Res. Commun. 289:1218–1224.

    PubMed  CAS  Google Scholar 

  • Simpson, I. A., Appel, N. M., Hokari, M., Oki, J., Holman, G. D., Maher, F., Koehler-Stec, E. M., Vannucci, S. J., and Smith, Q. R. (1999). Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J. Neurochem. 72:238–247.

    PubMed  CAS  Google Scholar 

  • Simpson, I. A., Chundu, K. R., Davies-Hill, T., Honer, W. G., and Davies, P. (1994). Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer’s disease. Ann. Neurol. 35:546–551.

    PubMed  CAS  Google Scholar 

  • Simpson, I. A., Vannucci, S. J., Dejoseph, M. R., and Hawkins, R. A. (2001). Glucose transporter asymmetries in the bovine blood-brain barrier. J. Biol. Chem. 276:12725–12729.

    PubMed  CAS  Google Scholar 

  • Tomatis, R., Marastoni, M., Balboni, G., Guerrini, R., Capasso, A., Sorrentino, L., Santagada, V., Caliendo, G., Lazarus, L. H., and Salvadori, S. (1997). Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides. J. Med. Chem. 40:2948–2952.

    PubMed  CAS  Google Scholar 

  • Vannucci, S. J., Reinhart, R., Maher, F., Bondy, C. A., Lee, W. H., Vannucci, R. C., and Simpson, I. A. (1998). Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain. Dev. Brain Res. 107:255–264.

    CAS  Google Scholar 

  • Varga-Defterdarovic, L., Horvat, S., Chung, N. N., and Schiller, P. W. (1992). Glycoconjugates of opioid peptides: Synthesis and biological activity of [Leu5] enkephalin related glycoconjugates with amide type of linkage. Int. J. Pept. Protein Res. 39:12–17.

    Article  PubMed  CAS  Google Scholar 

  • Waddell, I. D., Zomerschoe, A. G., Voice, M. W., and Burchell, A. (1992). Cloning and expression of a hepatic microsomal transport protein. Comparison with liver plasma-membrane glucose transport protein GLUT2. Biochem. J. 286:173–177.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Marine Drug and Food Institute, Ocean University of China, Qingdao, 266003, China

    Guo Xiuli & Geng Meiyu

  2. Department of Pharmacology, School of Pharmacy, Shandong University, Jinan, 250012, China

    Guo Xiuli

  3. Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China

    Du Guanhua

Authors
  1. Guo Xiuli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geng Meiyu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Du Guanhua
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Geng Meiyu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiuli, G., Meiyu, G. & Guanhua, D. Glucose Transporter 1, Distribution in the Brain and in Neural Disorders: Its Relationship With Transport of Neuroactive Drugs Through the Blood-Brain Barrier. Biochem Genet 43, 175–187 (2005). https://doi.org/10.1007/s10528-005-1510-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10528-005-1510-5

Keywords:

Search

Navigation